Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$10.56 USD
-0.31 (-2.85%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $10.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Pediatrix Medical Group, Inc. [MD]
Reports for Purchase
Showing records 241 - 260 ( 350 total )
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Relatively inline quarter; lowering rating to HOLD on valuation
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Solid organic trends plus high appetite for acquisitions to fuel additional growth
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Solid 4Q, 1Q Conservative, Outlook Remains Positive - Affirm Buy and Raise PT from $95 to $110
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Raising estimates for anesthesia acquisition and Medicaid parity ruling
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
3Q Beats By $0.05. 4Q Guidance Well Above Consensus. Reimbursement Parity Will Help In 2013, 2014. Anesthesia Acceleration Just Beginning. Expect Breakout Year In 2013. Affirm Buy Rating And $95 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Better than expected results; CMS finalizes Medicaid parity, estimates to increase
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Preliminary low weight birth data reflects solid 3Q12 trends
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Investor Meeting Highlights Anesthesia Opportunity. Acceleration Just Beginning. Expect Breakout .
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Analyst Day sets the stage for national anesthesia presence
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD Q2/12 Surprise on upside, Acquisition activity picks up Maintain Buy and $80.00 price target
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD Better than expected results inline with our propriety research; raising estimates
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
MD: Solid 2Q. Anesthesia To Accelerate. Reimbursement To Increase. Affirm Buy And Raise PT To $95.
Provider: COLLIERS SECURITIES
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Preliminary birth weight data suggests improving Pediatrix trends
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
ACA Should Result In Favorable Reimbursement. Also Expect Anesthesia Acceleration To Contribute To Faster Growth. Affirm Buy Rating And $80 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B